Department of Medicine, Section of Infectious Diseases, MS: BCM 286, Room N-1319, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Nat Rev Urol. 2011 Dec 6;9(2):85-93. doi: 10.1038/nrurol.2011.192.
Asymptomatic bacteriuria (ABU) is a condition in which bacteria are present in a noncontaminated urine sample collected from a patient without signs or symptoms related to the urinary tract. ABU must be distinguished from symptomatic UTI by the absence of signs and symptoms compatible with UTI or by clinical determination that a nonurinary etiology accounts for the patient's symptoms. Interactions between the organism, the host, and the bladder environment determine whether bacteriuria leads to ABU or to UTI. ABU is a very common condition that is often treated unnecessarily with antibiotics-it should be detected and treated in pregnant women and patients undergoing urologic surgery, but in most other patient groups, treatment does not confer benefit and can be harmful. A change in prescribing behavior for ABU has been achieved through several fairly high-intensity interventions, such as interactive educational sessions for physicians, but whether these improvements persist beyond the study period is not known. Further research is needed to determine whether screening for and treatment of ABU is beneficial in patients with renal transplants, patients with orthotopic neobladders, patients undergoing prosthetic joint implantation, and patients with neutropenia.
无症状性菌尿症(ABU)是指从患者采集的非污染尿液样本中存在细菌,但无与尿路感染相关的体征或症状。ABU 必须通过无符合尿路感染的体征和症状或通过临床确定非尿源性病因引起患者症状来与有症状的尿路感染(UTI)相区分。生物体、宿主和膀胱环境之间的相互作用决定了菌尿是否导致 ABU 或 UTI。ABU 是一种非常常见的病症,经常不必要地使用抗生素进行治疗 - 它应该在孕妇和接受泌尿科手术的患者中进行检测和治疗,但在大多数其他患者群体中,治疗没有益处,反而可能有害。通过一些高强度的干预措施,如针对医生的互动式教育课程,已经实现了针对 ABU 的处方行为的改变,但这些改善是否在研究期结束后仍然存在尚不清楚。需要进一步研究以确定在肾移植患者、原位新膀胱患者、接受人工关节植入患者和中性粒细胞减少症患者中筛查和治疗 ABU 是否有益。